MB Hiperbarinė deguonies terapija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
1 |
10 |
0 |
11 |
2023 |
---|
22,462 |
- |
-458 |
-458 |
- |
83.61 |
-2.04 |
6,842 |
47,211 |
51,903 |
2,150 |
2024 |
---|
33,932 |
- |
-6,379 |
-6,379 |
- |
83.09 |
-18.80 |
463 |
41,864 |
40,274 |
2,053 |
Register and
explore Okredo data2024 |
---|
33,932 |
- |
-6,379 |
-6,379 |
- |
83.09 |
-18.80 |
463 |
41,864 |
40,274 |
2,053 |
Register and
explore Okredo data2024
Turnover (€)
33,932 €51 % *
Sales per employee (€)
-Profit before tax (€)
-6,379 €-1,293 % *
Net Profit (€)
-6,379 €-1,293 % *
Profit per employee (€)
-Total profitability (%)
83.09 %-0.62 % *
Net profitability (%)
-18.80 %-821.57 % *
Equity (€)
463 €-93 % *
Amounts Payable And Liabilities (€)
41,864 €-11 % *
Non-current Assets (€)
40,274 €-22 % *
CurrentAssets (€)
2,053 €-5 % *